Skip to content

TOADS Study: TO Assess Death From Septic Shock.

Epidemiological Survey of Death Modalities in Patients With Septic Shock Referred to French Intensive Care Units: TOADS Study.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02547467
Acronym
TOADS
Enrollment
340
Registered
2015-09-11
Start date
2015-09-30
Completion date
2016-05-31
Last updated
2015-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Keywords

mortality

Brief summary

The aim of this study is to assess the causes of death in patients with septic shock in French intensive care units. It is an epidemiologic and descriptive study .

Detailed description

The purpose of this epidemiologic study is to describe with accuracy the reasons and causes of death in patients with septic shock during patients stay in intensive care units. All deceased patients with primary diagnosis of septic shock will be included in this survey and patients baseline characteristics as well as the clinical and data at the time of patient's death will be recorded.

Interventions

There is no intervention as it is a pure observational study for epidemiologic survey.

Sponsors

Laboratoire français de Fractionnement et de Biotechnologies
CollaboratorINDUSTRY
University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient * Died of septic shock in the intensive care unit (ICU) * At least 6 hours of vasopressors

Exclusion criteria

* Legally protected adult patient. * Less than 6 hours of vasopressors * Opposition to participation in the study expressed by the patient, family or person of trust

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome of this study is to identify the reasons of death of patients with septic shock via a questionnaire.Patients will be followed during their hospital stay, with a maximal follow up of 90 daysRecording of the context and the cause of death with a questionnaire

Contacts

Primary ContactPierre ASFAR, MD-PhD
piasfar@chu-angers.fr+33(0)241353815

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026